Jing Qian

1.0k total citations
42 papers, 823 citations indexed

About

Jing Qian is a scholar working on Cellular and Molecular Neuroscience, Ophthalmology and Oncology. According to data from OpenAlex, Jing Qian has authored 42 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Ophthalmology and 8 papers in Oncology. Recurrent topics in Jing Qian's work include Retinal Diseases and Treatments (7 papers), Neuropeptides and Animal Physiology (6 papers) and Chemokine receptors and signaling (5 papers). Jing Qian is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Neuropeptides and Animal Physiology (6 papers) and Chemokine receptors and signaling (5 papers). Jing Qian collaborates with scholars based in China, United States and Canada. Jing Qian's co-authors include Pranela Rameshwar, Pedro Gascón, Deval D. Joshi, Paul Maloof, Thomas N. Denny, Ghassan Yehia, Meera Hameed, Jonathan S. Harrison, Anne C. Mosenthal and Ramaswamy Narayanan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Jing Qian

40 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Qian China 16 293 253 156 93 93 42 823
Stephen J. Oliver United States 19 240 0.8× 116 0.5× 111 0.7× 82 0.9× 186 2.0× 27 1.1k
Elia Sechi Italy 25 301 1.0× 158 0.6× 213 1.4× 108 1.2× 103 1.1× 93 2.0k
Dong‐Fu Feng China 22 615 2.1× 225 0.9× 84 0.5× 62 0.7× 66 0.7× 56 1.3k
Irene Gutiérrez‐Cañas Spain 24 374 1.3× 382 1.5× 337 2.2× 139 1.5× 84 0.9× 39 1.3k
Josefine Radke Germany 18 372 1.3× 125 0.5× 132 0.8× 91 1.0× 83 0.9× 42 1.2k
Zhongshu Tang China 20 593 2.0× 234 0.9× 118 0.8× 49 0.5× 46 0.5× 35 1.1k
Satoru Ishibashi Japan 20 381 1.3× 184 0.7× 108 0.7× 143 1.5× 160 1.7× 66 1.3k
Marios Themistocleous Greece 19 254 0.9× 164 0.6× 97 0.6× 128 1.4× 78 0.8× 83 1.1k
Charlene D. Richardson United States 9 629 2.1× 163 0.6× 85 0.5× 183 2.0× 169 1.8× 13 1.3k
Sheila Mun-Bryce United States 13 461 1.6× 116 0.5× 118 0.8× 80 0.9× 75 0.8× 14 1.5k

Countries citing papers authored by Jing Qian

Since Specialization
Citations

This map shows the geographic impact of Jing Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Qian more than expected).

Fields of papers citing papers by Jing Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Qian. The network helps show where Jing Qian may publish in the future.

Co-authorship network of co-authors of Jing Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Qian. A scholar is included among the top collaborators of Jing Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Qian. Jing Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shasha, Jun Kong, Qi Zhang, et al.. (2025). Therapeutic potential of voltage-dependent potassium channel subtype 1.3 blockade in alleviating macrophage-related renal inflammation and fibrogenesis. Cell Death Discovery. 11(1). 218–218. 1 indexed citations
2.
Yang, Yuhui, Jing Qian, Yuncong Xu, et al.. (2024). Fecal microbiota transplantation from methionine-restricted diet mouse donors reduces fat deposition in obese mice by remodeling the gut microbiota. Food Bioscience. 59. 104255–104255. 3 indexed citations
3.
Li, Jue, et al.. (2023). The Influence of Overminus Lens Therapy on Control of Intermittent Exotropia: A Meta-Analysis of Randomized Clinical Trials. Ophthalmic Research. 66(1). 645–652. 1 indexed citations
4.
Qian, Jing, et al.. (2023). The Influence of Part-Time Occlusion Therapy on Control of Intermittent Exotropia: A Meta-Analysis of Randomized Controlled Trials. Ophthalmic Research. 66(1). 801–808. 2 indexed citations
5.
Cheng, Haixia, Di Cao, Jing Qian, et al.. (2023). Refractive status and retinal morphology in children with a history of intravitreal ranibizumab for retinopathy of prematurity. European Journal of Pediatrics. 182(7). 3121–3128. 2 indexed citations
6.
Yang, Yuhui, Manman Lu, Yuncong Xu, et al.. (2022). High dietary methionine intake may contribute to the risk of nonalcoholic fatty liver disease by inhibiting hepatic H2S production. Food Research International. 158. 111507–111507. 9 indexed citations
8.
Chen, Danni, et al.. (2022). Comparison of alternate part-time patching and pencil push-up training for patients with intermittent exotropia. BMC Ophthalmology. 22(1). 457–457. 4 indexed citations
9.
Bliss, Sarah A., Seda Ayer, Garima Sinha, et al.. (2020). Neuroimmune/Hematopoietic Axis with Distinct Regulation by the High-Mobility Group Box 1 in Association with Tachykinin Peptides. The Journal of Immunology. 204(4). 879–891. 7 indexed citations
10.
Wang, Fudong, Yuan Weng, Jun Zhu, et al.. (2019). A Rare Case of Hepatoid Adenocarcinoma in the Lung and Literature Review. 4(1).
11.
Qian, Jing, et al.. (2018). Necessity of adjuvant postoperative radiotherapy for diffuse pigmented villonodular synovitis of the knee. Medicine. 97(3). e9637–e9637. 10 indexed citations
12.
13.
Feng, Jing, Jing Qian, Yanrong Jiang, et al.. (2016). Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China. Ophthalmology. 124(3). 408–409. 31 indexed citations
14.
Dong, Zhizhen, Min Yao, Jing Qian, et al.. (2013). [Abnormal expression of insulin-like growth factor-II and intervening of its mRNA transcription in the promotion of HepG2 cell apoptosis].. PubMed. 93(12). 892–6. 4 indexed citations
15.
Zhou, Dong, Jing Qian, Hong Chang, Bo Xi, & Ruopeng Sun. (2011). Pyruvate administered to newborn rats with insulin-induced hypoglycemic brain injury reduces neuronal death and cognitive impairment. European Journal of Pediatrics. 171(1). 103–109. 10 indexed citations
16.
Qian, Jing & Yanrong Jiang. (2010). Anatomic Evaluation of Macular Holes with Silicone Oil Tamponades in Highly Myopic Eyes Using Optical Coherence Tomography. European Journal of Ophthalmology. 20(5). 938–944. 15 indexed citations
18.
Qian, Jing, Ghassan Yehia, Carlos A. Molina, et al.. (2001). Cloning of Human Preprotachykinin-I Promoter and the Role of Cyclic Adenosine 5′-Monophosphate Response Elements in Its Expression by IL-1 and Stem Cell Factor. The Journal of Immunology. 166(4). 2553–2561. 45 indexed citations
19.
Rameshwar, Pranela, Deval D. Joshi, Prem N. Yadav, et al.. (2001). Mimicry between neurokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosis. Blood. 97(10). 3025–3031. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026